FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Tetsuo Shoji

Research Profile

Disorders

Procedures

Renal Dialysis

Concepts & Ideas

Anatomy

Geographic Areas

Japan

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Toshihide Naganuma; Eiji Ishimura; Mikio Okamura; Hideaki Shima; Tetsuo Shoji; Yoshiaki Takemoto; Tatsuya Nakatani
Factors associated with cerebral white matter hyperintensities in haemodialysis patients.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Tetsuo Shoji (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Katsuhito Mori; Senji Okuno; Shigeichi Shoji; Tetsuo Shoji; Kenjiro Yamakawa; Tomoyuki Yamakawa; Masanori Emoto; Yasuo Imanishi; Eiji Ishimura; Yoshinori Kakutani; Masaaki Inaba
Tumor necrosis factor-related apoptosis-inducing ligand as an independent predictor of mortality in hemodialysis patents.
Cytokine 2013;61(3):912-6.
2013: Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Naoya Kawano; Eiko Lee; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Masaaki Inaba
Clinical impact of the leptin to soluble leptin receptor ratio on subclinical carotid atherosclerosis in patients with type 2 diabetes.
Journal of atherosclerosis and thrombosis 2013;20(2):186-94.
2012: Toshihide Naganuma; Eiji Ishimura; Mikio Okamura; Hideaki Shima; Tetsuo Shoji; Yoshiaki Takemoto; Tatsuya Nakatani
Factors associated with cerebral white matter hyperintensities in haemodialysis patients.
Nephrology (Carlton, Vic.) 2012;17(6):561-8.
2012: Tetsuo Shoji
[Kidney and bone update : the 5-year history and future of CKD-MBD. Progress in therapy of CKD-MBD with vitamin D receptor activators].
Clinical calcium 2012;22(7):1073-81.
2012: Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Eiji Kimoto; Hidenori Koyama; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Shigeichi Shoji; Tetsuo Shoji; Ken Wakikawa; Masanori Emoto
Antialbuminuric advantage of cilnidipine compared with L-type calcium channel blockers in type 2 diabetic patients with normoalbuminuria and microalbuminuria.
Diabetes research and clinical practice 2012;97(1):91-8.
2012: Tetsuo Shoji; Tatsuji Takahashi; Masanori Emoto; Shinya Fukumoto; Akihide Matsumoto; Katsuhito Mori; Tomoaki Morioka; Yoshiki Nishizawa; Masaaki Inaba
Thrice-weekly insulin injection with nurse's support for diabetic hemodialysis patients having difficulty with self injection.
Osaka city medical journal 2012;58(1):35-8.
2012: Maki Yoda; Yasuo Imanishi; Masaaki Inaba; Eiji Ishimura; Katsuhito Mori; Senji Okuno; Tetsuo Shoji; Shinsuke Yamada; Tomoyuki Yamakawa; Koichiro Yoda; Shigeichi Shoji
Poor muscle quality as a predictor of high mortality independent of diabetes in hemodialysis patients.
Biomedicine & pharmacotherapy = Biomédecine & pharmacothérapie 2012;66(4):266-70.
2012: Tetsuo Shoji
[Chronic kidney disease (CKD)--recent progress. Topics: VI. Chronic kidney disease (CKD) and associated disorders; 4. Dyslipidemia in chronic kidney disease].
Nihon Naika Gakkai zasshi. The Journal of the Japanese Society of Internal Medicine 2012;101(5):1294-302.
2012: Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Tetsuo Shoji; Shinsuke Yamada; Masanori Emoto; Yasuo Imanishi; Eiko Lee; Masaaki Inaba
Undercarboxylated osteocalcin does not correlate with insulin resistance as assessed by euglycemic hyperinsulinemic clamp technique in patients with type 2 diabetes mellitus.
Diabetology & metabolic syndrome 2012;4(1):53.
2012: Yohei Mima; Yoshiki Nishizawa; Masahiro Okada; Tetsuo Shoji; Shinji Tanaka; Masanori Emoto; Shinya Fukumoto; Tsutomu Furuzono; Hidenori Koyama; Masaaki Inaba
Enhancement of cell-based therapeutic angiogenesis using a novel type of injectable scaffolds of hydroxyapatite-polymer nanocomposite microspheres.
PloS one 2012;7(4):e35199.
2012: Masaaki Inaba; Kiyoshi Kurokawa; Akira Saito; Tetsuo Shoji; Takashi Akiba; Tadao Akizawa; Yasuaki Hayashino; Shunichi Fukuhara
Disappearance of association in diabetic patients on hemodialysis between anemia and mortality risk: the Japan dialysis outcomes and practice pattern study.
Nephron. Clinical practice 2012;120(2):c91-c100.
2012: Tetsuo Shoji; Yoshimitsu Yamasaki; Takaaki Abe; Genshi Egusa; Naoki Kashihara; Atsunori Kashiwagi; Hiroshi Matsuo; Kohji Shirai
Chronic kidney disease, dyslipidemia, and atherosclerosis.
Journal of atherosclerosis and thrombosis 2012;19(4):299-315.
2012: Naoya Kawano; Hidenori Koyama; Katsuhito Mori; Tomoaki Morioka; Koka Motoyama; Yoshiki Nishizawa; Yasuhisa Okuno; Tetsuo Shoji; Shoko Tsuchikura; Hiromi Urata; Yuko Yamazaki; Masanori Emoto; Shinya Fukumoto; Masaaki Inaba
Association of endothelial and vascular smooth muscle dysfunction with cardiovascular risk factors, vascular complications, and subclinical carotid atherosclerosis in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2012;19(3):276-84.
2012: Satoshi Maeda; Toshihide Naganuma; Mikio Okamura; Tetsuo Shoji; Yoshiaki Takemoto; Tatsuya Nakatani
Chronic kidney disease in urolithiasis patients following successful extracorporeal shockwave lithotripsy.
Molecular medicine reports 2012;5(1):3-6.
2011: Akinobu Ochi; Tetsuo Shoji; Tsutomu Tabata; Yoshihiro Tsujimoto; Hiroshi Yasuda; Eiji Ishimura; Ryusuke Kakiya; Katsuhito Mori; Yoshiki Nishizawa; Masaaki Inaba
Trace elements in the hair of hemodialysis patients.
Biological trace element research 2011;143(2):825-34.
2011: Yoshihiro Tsujimoto; Masanori Emoto; Eiji Ishimura; Hidenori Koyama; Yoshiki Nishizawa; Tetsuo Shoji; Tsutomu Tabata; Hideki Tahara; Masaaki Inaba
Active vitamin D and acute respiratory infections in dialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(6):1361-7.
2011: Tetsuo Shoji; Yoshiharu Tsubakihara; Yuzo Watanabe; Kunitoshi Iseki; Ikuto Masakane
Elevated non-high-density lipoprotein cholesterol (non-HDL-C) predicts atherosclerotic cardiovascular events in hemodialysis patients.
Clinical journal of the American Society of Nephrology : CJASN 2011;6(5):1112-20.
2011: T Naganuma; Y Takemoto; T Yamasaki; H Shima; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa; M Morino; M Okamura; T Nakatani
Factors associated with silent cerebral microbleeds in hemodialysis patients.
Clinical nephrology 2011;75(4):346-55.
2011: Hiroki Ueno; Hidenori Koyama; Shinya Fukumoto; Shinji Tanaka; Tetsuo Shoji; Tetsuo Shoji; Masanori Emoto; Hideki Tahara; Masaaki Inaba; Ryusuke Kakiya; Tsutomu Tabata; Toshio Miyata; Yoshiki Nishizawa
Advanced glycation end products, carotid atherosclerosis, and circulating endothelial progenitor cells in patients with end-stage renal disease.
Metabolism: clinical and experimental 2011;60(4):453-9.
2011: Naoya Kawano; Katsuhito Mori; Masanori Emoto; Eiko Lee; Ikue Kobayashi; Yuko Yamazaki; Hiromi Urata; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Association of serum TRAIL levels with atherosclerosis in patients with type 2 diabetes mellitus.
Diabetes research and clinical practice 2011;91(3):316-20.
2011: Takeshi Yamasaki; Toshihide Naganuma; Taro Iguchi; Yoshikazu Kuroki; Nobuyuki Kuwabara; Yoshiaki Takemoto; Tetsuo Shoji; Tatsuya Nakatani
Association between chronic kidney disease and small residual urine volumes in patients with benign prostatic hyperplasia.
Nephrology (Carlton, Vic.) 2011;16(3):335-9.
2011: Hiroki Ueno; Masanori Emoto; Shinya Fukumoto; Hidenori Koyama; Yohei Mima; Yoshiki Nishizawa; Takuhito Shoji; Tetsuo Shoji; Shinji Tanaka; Masaaki Inaba
Comparison of the effect of cilostazol with aspirin on circulating endothelial progenitor cells and small-dense LDL cholesterol in diabetic patients with cerebral ischemia: a randomized controlled pilot trial.
Journal of atherosclerosis and thrombosis 2011;18(10):883-90.
2010: Yohei Mima; Shinya Fukumoto; Hiroki Ueno; Hidenori Koyama; Shinji Tanaka; Tomoaki Morioka; Koka Motoyama; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba
Different effects of diabetic autonomic neuropathy on regional transcutaneous oxygen tension in patients with peripheral arterial disease.
Osaka city medical journal 2010;56(2):27-36.
2010: Tetsuo Shoji
[Benefit of vitamin D receptor activation in CKD].
Clinical calcium 2010;20(12):1886-9.
2010: Hiroki Ueno; Shinya Fukumoto; Hidenori Koyama; Shinji Tanaka; Takaaki Maeno; Masahiro Murayama; Yoshiko Otsuka; Yohei Mima; Yuji Kawaguchi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Regions of arterial stenosis and clinical factors determining transcutaneous oxygen tension in patients with peripheral arterial disease.
Journal of atherosclerosis and thrombosis 2010;17(8):858-69.
2010: Shoko Tsuchikura; Tetsuo Shoji; Eiji Kimoto; Kayo Shinohara; Sawako Hatsuda; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Central versus peripheral arterial stiffness in association with coronary, cerebral and peripheral arterial disease.
Atherosclerosis 2010;211(2):480-5.
2010: Shoko Tsuchikura; Tetsuo Shoji; Eiji Kimoto; Kayo Shinohara; Sawako Hatsuda; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Brachial-ankle pulse wave velocity as an index of central arterial stiffness.
Journal of atherosclerosis and thrombosis 2010;17(6):658-65.
2010: Masanori Emoto; Katsuhito Mori; Eiko Lee; Naoya Kawano; Yuko Yamazaki; Shoko Tsuchikura; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Fetuin-A and atherosclerotic calcified plaque in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2010;59(6):873-8.
2010: Hideaki Shima; Eiji Ishimura; Toshihide Naganuma; Takeshi Yamazaki; Ikue Kobayashi; Kaori Shidara; Katsuhito Mori; Yoshiaki Takemoto; Tetsuo Shoji; Masaaki Inaba; Mikio Okamura; Tatsuya Nakatani; Yoshiki Nishizawa
Cerebral microbleeds in predialysis patients with chronic kidney disease.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(5):1554-9.
2010: Tetsuo Shoji; Kiyoshi Maekawa; Masanori Emoto; Senji Okuno; Tomoyuki Yamakawa; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Arterial stiffness predicts cardiovascular death independent of arterial thickness in a cohort of hemodialysis patients.
Atherosclerosis 2010;210(1):145-9.
2010: Hidenori Koyama; Sanae Fukuda; Tetsuo Shoji; Masaaki Inaba; Yoshihiro Tsujimoto; Tsutomu Tabata; Senji Okuno; Tomoyuki Yamakawa; Shigeki Okada; Mikio Okamura; Hirohiko Kuratsune; Hisako Fujii; Yoshinobu Hirayama; Yasuyoshi Watanabe; Yoshiki Nishizawa
Fatigue is a predictor for cardiovascular outcomes in patients undergoing hemodialysis.
Clinical journal of the American Society of Nephrology : CJASN 2010;5(4):659-66.
2010: Hiroki Ueno; Hidenori Koyama; Shinya Fukumoto; Shinji Tanaka; Tetsuo Shoji; Tetsuo Shoji; Masanori Emoto; Hideki Tahara; Yoshihiro Tsujimoto; Tsutomu Tabata; Yoshiki Nishizawa
Dialysis modality is independently associated with circulating endothelial progenitor cells in end-stage renal disease patients.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2010;25(2):581-6.
2010: Katsuhito Mori; Shuichi Jono; Masanori Emoto; Takahiko Kawagishi; Hideo Yasumoto; Toshiaki Konishi; Yutaka Furumitsu; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effects of pravastatin on serum osteoprotegerin levels in patients with hypercholesterolemia and type 2 diabetes.
Angiology 2010;61(1):86-91.
2010: Shoko Tsuchikura; Tetsuo Shoji; Naoko Shimomura; Ryusuke Kakiya; Masanori Emoto; Hidenori Koyama; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Serum C-reactive protein and thioredoxin levels in subjects with mildly reduced glomerular filtration rate.
BMC nephrology 2010;11():7.
2009: Tetsuo Shoji; Sawako Hatsuda; Shoko Tsuchikura; Eiji Kimoto; Ryusuke Kakiya; Hideki Tahara; Hidenori Koyama; Masanori Emoto; Tsutomu Tabata; Yoshiki Nishizawa
Plasma angiopoietin-like protein 3 (ANGPTL3) concentration is associated with uremic dyslipidemia.
Atherosclerosis 2009;207(2):579-84.
2009: Tetsuo Shoji; Yoshiki Nishizawa
[Chronic kidney disease (CKD) and bone. Pleiotropic actions of vitamin D and survival advantage].
Clinical calcium 2009;19(4):514-21.
2009: Eiko Lee; Masanori Emoto; Megumi Teramura; Shoko Tsuchikura; Hiroki Ueno; Kayo Shinohara; Tomoaki Morioka; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
The combination of IMT and stiffness parameter beta is highly associated with concurrent coronary artery disease in type 2 diabetes.
Journal of atherosclerosis and thrombosis 2009;16(1):33-9.
2009: Takahiro Araki; Masanori Emoto; Toshiaki Konishi; Yoshiko Ikuno; Eiko Lee; Megumi Teramura; Koka Motoyama; Hisayo Yokoyama; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa
Glimepiride increases high-density lipoprotein cholesterol via increasing adiponectin levels in type 2 diabetes mellitus.
Metabolism: clinical and experimental 2009;58(2):143-8.
2009: Tetsuo Shoji; Sawako Hatsuda; Shoko Tsuchikura; Kayo Shinohara; Eiji Kimoto; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Small dense low-density lipoprotein cholesterol concentration and carotid atherosclerosis.
Atherosclerosis 2009;202(2):582-8.
2008: Hiroki Ueno; Hidenori Koyama; Shinji Tanaka; Shinya Fukumoto; Kayo Shinohara; Tetsuo Shoji; Masanori Emoto; Hideki Tahara; Ryusuke Kakiya; Tsutomu Tabata; Toshio Miyata; Yoshiki Nishizawa
Skin autofluorescence, a marker for advanced glycation end product accumulation, is associated with arterial stiffness in patients with end-stage renal disease.
Metabolism: clinical and experimental 2008;57(10):1452-7.
2008: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Eiko Lee; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effects of pioglitazone on serum fetuin-A levels in patients with type 2 diabetes mellitus.
Metabolism: clinical and experimental 2008;57(9):1248-52.
2008: Tetsuo Shoji; Yoshiharu Tsubakihara; Shigeru Nakai; Yoshiki Nishizawa
Reverse epidemiology in hemodialysis patients. Lessons from Japanese registries.
Néphrologie & thérapeutique 2008;4(4):223-7.
2008: Eiji Ishimura; Senji Okuno; Hiromichi Taniwaki; Akane Kizu; Takao Tsuchida; Atsushi Shioi; Tetsuo Shoji; Tsutomu Tabata; Masaaki Inaba; Yoshiki Nishizawa
Different risk factors for vascular calcification in end-stage renal disease between diabetics and nondiabetics: the respective importance of glycemic and phosphate control.
Kidney & blood pressure research 2008;31(1):10-5.
2007: Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
Body fat measurement in chronic kidney disease: implications in research and clinical practice.
Current opinion in nephrology and hypertension 2007;16(6):572-6.
2007: Megumi Teramura; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Koka Motoyama; Kayo Shinohara; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Clinical impact of metabolic syndrome by modified NCEP-ATPIII criteria on carotid atherosclerosis in Japanese adults.
Journal of atherosclerosis and thrombosis 2007;14(4):172-8.
2007: Eiji Ishimura; Hiromichi Taniwaki; Takao Tsuchida; Naoko Obatake; Masanori Emoto; Tetsuo Shoji; Atsushi Shioi; Masaaki Inaba; Yoshiki Nishizawa
Urinary albumin excretion associated with arterial wall stiffness rather than thickness in type 2 diabetic patients.
Journal of nephrology 2007;20(2):204-11.
2007: Katsuhito Mori; Masanori Emoto; Takahiro Araki; Hisayo Yokoyama; Megumi Teramura; Eiko Lee; Koka Motoyama; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of serum fetuin-A with carotid arterial stiffness.
Clinical endocrinology 2007;66(2):246-50.
2007: Sawako Hatsuda; Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Association between plasma angiopoietin-like protein 3 and arterial wall thickness in healthy subjects.
Journal of vascular research 2007;44(1):61-6.
2007: Hidenori Koyama; Tetsuo Shoji; Shinya Fukumoto; Kayo Shinohara; Tetsuo Shoji; Masanori Emoto; Katsuhito Mori; Hideki Tahara; Eiji Ishimura; Ryusuke Kakiya; Tsutomu Tabata; Hiroshi Yamamoto; Yoshiki Nishizawa
Low circulating endogenous secretory receptor for AGEs predicts cardiovascular mortality in patients with end-stage renal disease.
Arteriosclerosis, thrombosis, and vascular biology 2007;27(1):147-53.
2006: Tetsuo Shoji; Hidenori Koyama; Shinya Fukumoto; Takaaki Maeno; Hisayo Yokoyama; Kayo Shinohara; Masanori Emoto; Tetsuo Shoji; Takahisa Yamane; Masayuki Hino; Atsushi Shioi; Yoshiki Nishizawa
Platelet activation is associated with hypoadiponectinemia and carotid atherosclerosis.
Atherosclerosis 2006;188(1):190-5.
2006: Tetsuo Shoji; Yoshiki Nishizawa
Plasma lipoprotein abnormalities in hemodialysis patients--clinical implications and therapeutic guidelines.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2006;10(4):305-15.
2006: Tetsuo Shoji; Hidenori Koyama; Tomoaki Morioka; Shinji Tanaka; Akane Kizu; Kohka Motoyama; Katsuhito Mori; Shinya Fukumoto; Atsushi Shioi; Noriko Shimogaito; Masayoshi Takeuchi; Yasuhiko Yamamoto; Hideto Yonekura; Hiroshi Yamamoto; Yoshiki Nishizawa
Receptor for advanced glycation end products is involved in impaired angiogenic response in diabetes.
Diabetes 2006;55(8):2245-55.
2006: Takahiro Araki; Masanori Emoto; Megumi Teramura; Hisayo Yokoyama; Katsuhito Mori; Sawako Hatsuda; Takaaki Maeno; Kayo Shinohara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Effect of adiponectin on carotid arterial stiffness in type 2 diabetic patients treated with pioglitazone and metformin.
Metabolism: clinical and experimental 2006;55(8):996-1001.
2006: Eiji Kimoto; Tetsuo Shoji; Kayo Shinohara; Sawako Hatsuda; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yasuhisa Okuno; Yoshiki Nishizawa
Regional arterial stiffness in patients with type 2 diabetes and chronic kidney disease.
Journal of the American Society of Nephrology : JASN 2006;17(8):2245-52.
2006: R Kakiya; Tetsuo Shoji; Yoshihiro Tsujimoto; N Tatsumi; Sawako Hatsuda; Kayo Shinohara; Eiji Kimoto; Hideki Tahara; Hidenori Koyama; Masanori Emoto; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Body fat mass and lean mass as predictors of survival in hemodialysis patients.
Kidney international 2006;70(3):549-56.
2006: Yoshiki Nishizawa; Tetsuo Shoji
Does paricalcitol reduce proteinuria in patients with chronic kidney disease?
Nature clinical practice. Nephrology 2006;2(7):352-3.
2006: Yoshiki Nishizawa; Tetsuo Shoji; Eiji Ishimura
Body composition and cardiovascular risk in hemodialysis patients.
Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation 2006;16(3):241-4.
2006: Tetsuo Shoji; Yoshiki Nishizawa
[Effects of vitamin D on the cardiovascular system].
Clinical calcium 2006;16(7):1107-14.
2006: Takeshi Oomichi; Masanori Emoto; Tsutomu Tabata; Tomoaki Morioka; Yoshihiro Tsujimoto; Hideki Tahara; Tetsuo Shoji; Yoshiki Nishizawa
Impact of glycemic control on survival of diabetic patients on chronic regular hemodialysis: a 7-year observational study.
Diabetes care 2006;29(7):1496-500.
2006: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Takaaki Maeno; Sawako Hatsuda; Katsuhito Mori; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
The association of plasma adiponectin level with carotid arterial stiffness.
Metabolism: clinical and experimental 2006;55(5):587-92.
2006: Sawako Hatsuda; Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Katsuhito Mori; Shinya Fukumoto; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Regional arterial stiffness associated with ischemic heart disease in type 2 diabetes mellitus.
Journal of atherosclerosis and thrombosis 2006;13(2):114-21.
2006: Hisayo Yokoyama; Masanori Emoto; Katsuhito Mori; Takahiro Araki; Megumi Teramura; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Plasma adiponectin level is associated with insulin-stimulated nonoxidative glucose disposal.
The Journal of clinical endocrinology and metabolism 2006;91(1):290-4.
2005: Hidenori Koyama; Tetsuo Shoji; Hisayo Yokoyama; Kohka Motoyama; Katsuhito Mori; Shinya Fukumoto; Masanori Emoto; Tetsuo Shoji; Hironori Tamei; Hirokazu Matsuki; Shigeru Sakurai; Yasuhiko Yamamoto; Hideto Yonekura; Takuo Watanabe; Hiroshi Yamamoto; Yoshiki Nishizawa
Plasma level of endogenous secretory RAGE is associated with components of the metabolic syndrome and atherosclerosis.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(12):2587-93.
2005: Hiromichi Taniwaki; Eiji Ishimura; Tsutomu Tabata; Yoshihiro Tsujimoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Takashi Inoue; Yoshiki Nishizawa
Aortic calcification in haemodialysis patients with diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2005;20(11):2472-8.
2005: Hideki Tahara; Yoshihiro Tsujimoto; Tetsuo Shoji; Masaaki Inaba; Tsutomu Tabata; Yoshiki Nishizawa
Introduction to sevelamer hydrochloride and its clinical effects.
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis Therapy 2005;9 Suppl 1():S2-6.
2005: Takahiro Araki; Masanori Emoto; Hisayo Yokoyama; Koka Motoyama; Tomoaki Morioka; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
Insulin resistance index as a predictor for pioglitazone treatment in type 2 diabetes.
Osaka city medical journal 2005;51(1):19-25.
2005: Eiji Ishimura; Hiromichi Taniwaki; Tsutomu Tabata; Yoshihiro Tsujimoto; Shuichi Jono; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Takashi Inoue; Yoshiki Nishizawa
Cross-sectional association of serum phosphate with carotid intima-medial thickness in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2005;45(5):859-65.
2005: Tetsuo Shoji; Yoshiki Nishizawa
Chronic kidney disease as a metabolic syndrome with malnutrition--need for strict control of risk factors.
Internal medicine (Tokyo, Japan) 2005;44(3):179-87.
2005: Hisayo Yokoyama; Hideki Tahara; Masanori Emoto; Shigehiko Fujiwara; Takahiro Araki; Kayo Shinohara; Sawako Hatsuda; Takaaki Maeno; Takuhito Shoji; Hidenori Koyama; Tetsuo Shoji; Yoshiki Nishizawa
The K469E polymorphism of the intercellular adhesion molecule-1 gene is associated with plasma fibrinogen level in type 2 diabetes.
Metabolism: clinical and experimental 2005;54(3):381-6.
2005: Tetsuo Shoji; Kayo Shinohara; Sawako Hatsuda; Eiji Kimoto; Shinya Fukumoto; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Altered relationship between body fat and plasma adiponectin in end-stage renal disease.
Metabolism: clinical and experimental 2005;54(3):330-4.
2005: Tetsuo Shoji; Hidenori Koyama; Shinya Fukumoto; Takaaki Maeno; Hisayo Yokoyama; Kayo Shinohara; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Platelet-monocyte aggregates are independently associated with occurrence of carotid plaques in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2005;12(6):344-52.
2005: Kayo Shinohara; Tetsuo Shoji; Eiji Kimoto; Hisayo Yokoyama; Shigehiko Fujiwara; Sawako Hatsuda; Takaaki Maeno; Tetsuo Shoji; Shinya Fukumoto; Masanori Emoto; Hidenori Koyama; Yoshiki Nishizawa
Effect of atorvastatin on regional arterial stiffness in patients with type 2 diabetes mellitus.
Journal of atherosclerosis and thrombosis 2005;12(4):205-10.
2005: Shinsuke Yamada; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata; Misako Ueda; Kiyoshi Nakatuka; Hideki Tahara; Hisayo Yokoyama; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa
Significance of intima-media thickness in femoral artery in the determination of calcaneus osteo-sono index but not of lumbar spine bone mass in healthy Japanese people.
Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 2005;16(1):64-70.
2004: Tetsuo Shoji; Yoshiki Nishizawa
[Vitamin D and survival of hemodialysis patients].
Clinical calcium 2004;14(9):64-8.
2004: Yoshiki Nishizawa; Tetsuo Shoji; Masanori Emoto; Hideki Koyama; Hideki Tahara; Shinya Fukumoto; Masaaki Inaba; Eiji Ishimura; Takami Miki
Roles of metabolic and endocrinological alterations in atherosclerosis and cardiovascular disease in renal failure: another form of metabolic syndrome.
Seminars in nephrology 2004;24(5):423-5.
2004: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Shuichi Jono; Tetsuo Shoji; Atsushi Shioi; Masaaki Inaba; Shaul G Massry; Yoshiki Nishizawa
C-reactive protein is a significant predictor of vascular calcification of both aorta and hand arteries.
Seminars in nephrology 2004;24(5):408-12.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Short-term aerobic exercise improves arterial stiffness in type 2 diabetes.
Diabetes research and clinical practice 2004;65(2):85-93.
2004: Hisayo Yokoyama; Masanori Emoto; Takahiro Araki; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Yasuhisa Okuno; Yoshiki Nishizawa
Effect of aerobic exercise on plasma adiponectin levels and insulin resistance in type 2 diabetes.
Diabetes care 2004;27(7):1756-8.
2004: Tetsuo Shoji; Eiji Kimoto; Kayo Shinohara; Sawako Hatsuda; Yoshiki Nishizawa
Molecular forms of adiponectin in uraemic plasma.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(7):1937-8.
2004: Tetsuo Shoji; Yoshiki Nishizawa
[Arteriosclerosis in renal failure].
Nihon rinsho. Japanese journal of clinical medicine 2004;62 Suppl 6():339-42.
2004: Reiko Okabe; Masaaki Inaba; Shinrei Sakai; Eiji Ishimura; Atushi Moriguchi; Tetsuo Shoji; Yoshiki Nishizawa
Increased arterial stiffening and thickening in the paretic lower limb in patients with hemiparesis.
Clinical science (London, England : 1979) 2004;106(6):613-8.
2004: Yasuo Imanishi; Masaaki Inaba; Kiyoshi Nakatsuka; Kyoko Nagasue; Senji Okuno; Asami Yoshihara; Masakazu Miura; Akimitsu Miyauchi; Keisuke Kobayashi; Takami Miki; Tetsuo Shoji; Eiji Ishimura; Yoshiki Nishizawa
FGF-23 in patients with end-stage renal disease on hemodialysis.
Kidney international 2004;65(5):1943-6.
2004: Eiko Lee; Hideki Tahara; Tetsuo Shoji; Mayumi Nagata; Misako Ueda; Shinsuke Yamada; Hitoshi Goto; Masaaki Inaba; Yoshiki Nishizawa
[Case Report No.138:One case of advanced renal hyperparathyroidim complicated with acute renal failure].
Clinical calcium 2004;14(3):462-5.
2004: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment are useful indexes of insulin resistance in type 2 diabetic patients with wide range of fasting plasma glucose.
The Journal of clinical endocrinology and metabolism 2004;89(3):1481-4.
2004: Kayo Shinohara; Tetsuo Shoji; Yoshihiro Tsujimoto; Eiji Kimoto; Hideki Tahara; Hidenori Koyama; Masanori Emoto; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Arterial stiffness in predialysis patients with uremia.
Kidney international 2004;65(3):936-43.
2004: Tetsuo Shoji; Kayo Shinohara; Eiji Kimoto; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Masaaki Inaba; Shinya Fukumoto; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Lower risk for cardiovascular mortality in oral 1alpha-hydroxy vitamin D3 users in a haemodialysis population.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2004;19(1):179-84.
2003: Senji Okuno; Eiji Ishimura; Kayoko Kitatani; Hidenori Chou; Kyoko Nagasue; Kiyoshi Maekawa; Tsuyoshi Izumotani; Tomoyuki Yamakawa; Yasuo Imanishi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Relationship between parathyroid gland size and responsiveness to maxacalcitol therapy in patients with secondary hyperparathyroidism.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2003;18(12):2613-21.
2003: Mayumi Nagata-Sakurai; Masaaki Inaba; Hitoshi Goto; Yasuro Kumeda; Yutaka Furumitsu; Kentaro Inui; Hidenori Koyama; Masanori Emoto; Eiji Ishimura; Tetsuo Shoji; Yoshiki Nishizawa
Inflammation and bone resorption as independent factors of accelerated arterial wall thickening in patients with rheumatoid arthritis.
Arthritis and rheumatism 2003;48(11):3061-7.
2003: Akane Kizu; Hidenori Koyama; Shinji Tanaka; Takaaki Maeno; Miyoko Komatsu; Shinya Fukumoto; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Atsushi Shioi; Takami Miki; Yoshiki Nishizawa
Arterial wall stiffness is associated with peripheral circulation in patients with type 2 diabetes.
Atherosclerosis 2003;170(1):87-91.
2003: Hidenori Koyama; Takaaki Maeno; Shinya Fukumoto; Tetsuo Shoji; Takahisa Yamane; Hisayo Yokoyama; Masanori Emoto; Tetsuo Shoji; Hideki Tahara; Masaaki Inaba; Masayuki Hino; Atsushi Shioi; Takami Miki; Yoshiki Nishizawa
Platelet P-selectin expression is associated with atherosclerotic wall thickness in carotid artery in humans.
Circulation 2003;108(5):524-9.
2003: Hisayo Yokoyama; Masanori Emoto; Shigehiko Fujiwara; Koka Motoyama; Tomoaki Morioka; Miyoko Komatsu; Hideki Tahara; Tetsuo Shoji; Yasuhisa Okuno; Yoshiki Nishizawa
Quantitative insulin sensitivity check index and the reciprocal index of homeostasis model assessment in normal range weight and moderately obese type 2 diabetic patients.
Diabetes care 2003;26(8):2426-32.
2003: Koka Motoyama; Masanori Emoto; Hideki Tahara; Miyoko Komatsu; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Association of muscle glycogen synthase polymorphism with insulin resistance in type 2 diabetic patients.
Metabolism: clinical and experimental 2003;52(7):895-9.
2003: Hideki Ueda; Eiji Ishimura; Tetsuo Shoji; Masanori Emoto; Tomoaki Morioka; Naoki Matsumoto; Shinya Fukumoto; Takami Miki; Masaaki Inaba; Yoshiki Nishizawa
Factors affecting progression of renal failure in patients with type 2 diabetes.
Diabetes care 2003;26(5):1530-4.
2003: Tetsuo Shoji; Eiji Kimoto; Kayo Shinohara; Masanori Emoto; Eiji Ishimura; Takami Miki; Yoshihiro Tsujimoto; Tsutomu Tabata; Yoshiki Nishizawa
The association of antibodies against oxidized low-density lipoprotein with atherosclerosis in hemodialysis patients.
Kidney international. Supplement 2003;(84):S128-30.
2003: Yoshiki Nishizawa; Tetsuo Shoji; Ryusuke Kakiya; Yoshihiro Tsujimoto; Tsutomu Tabata; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Non-high-density lipoprotein cholesterol (non-HDL-C) as a predictor of cardiovascular mortality in patients with end-stage renal disease.
Kidney international. Supplement 2003;(84):S117-20.
2003: Eiji Ishimura; Senji Okuno; Taro Marukawa; Yoshikazu Katoh; Toshiyuki Hiranaka; Tomoyuki Yamakawa; Hirotoshi Morii; Masao Kim; Naoki Matsumoto; Tetsuo Shoji; Masaaki Inaba; Tatsuya Nakatani; Yoshiki Nishizawa
Body fat mass in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S137-41.
2003: Yoshiki Nishizawa; Tetsuo Shoji; Kiyoshi Maekawa; Kyoko Nagasue; Senji Okuno; Masao Kim; Masanori Emoto; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Masaaki Inaba
Intima-media thickness of carotid artery predicts cardiovascular mortality in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2003;41(3 Suppl 1):S76-9.
2003: Eiji Kimoto; Tetsuo Shoji; Kayo Shinohara; Masaaki Inaba; Yasuhisa Okuno; Takami Miki; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Preferential stiffening of central over peripheral arteries in type 2 diabetes.
Diabetes 2003;52(2):448-52.
2003: Hisayo Yokoyama; Tetsuo Shoji; Eiji Kimoto; Kayo Shinohara; Shinji Tanaka; Hidenori Koyama; Masanori Emoto; Yoshiki Nishizawa
Pulse wave velocity in lower-limb arteries among diabetic patients with peripheral arterial disease.
Journal of atherosclerosis and thrombosis 2003;10(4):253-8.
2003: Shigehiko Fujiwara; Masanori Emoto; Miyoko Komatsu; Koka Motoyama; Tomoaki Morioka; Hidenori Koyama; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Arterial wall thickness is associated with insulin resistance in type 2 diabetic patients.
Journal of atherosclerosis and thrombosis 2003;10(4):246-52.
2003: Hiromichi Taniwaki; Eiji Ishimura; Takahiko Kawagishi; Naoki Matsumoto; Masayuki Hosoi; Masanori Emoto; Tetsuo Shoji; Shigeichi Shoji; Tatsuya Nakatani; Masaaki Inaba; Yoshiki Nishizawa
Intrarenal hemodynamic changes after captopril test in patients with type 2 diabetes: a duplex Doppler sonography study.
Diabetes care 2003;26(1):132-7.
2002: Tetsuo Shoji; Mariko Fukumoto; Eiji Kimoto; Kayo Shinohara; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Eiji Ishimura; Tatsuya Nakatani; Takami Miki; Yoshihiro Tsujimoto; Tsutomu Tabata; Yoshiki Nishizawa
Antibody to oxidized low-density lipoprotein and cardiovascular mortality in end-stage renal disease.
Kidney international 2002;62(6):2230-7.
2002: Eiji Ishimura; Senji Okuno; Kayoko Kitatani; Masao Kim; Tetsuo Shoji; T Nakatani; Masaaki Inaba; Yoshiki Nishizawa
Different risk factors for peripheral vascular calcification between diabetic and non-diabetic haemodialysis patients--importance of glycaemic control.
Diabetologia 2002;45(10):1446-8.
2002: Miyoko Komatsu; Takahiko Kawagishi; Masanori Emoto; Tetsuo Shoji; Atsuko Yamada; Kyoko Sato; Masayuki Hosoi; Yoshiki Nishizawa
ecNOS gene polymorphism is associated with endothelium-dependent vasodilation in Type 2 diabetes.
American journal of physiology. Heart and circulatory physiology 2002;283(2):H557-61.
2002: Kayo Shinohara; Tetsuo Shoji; Masanori Emoto; Hideki Tahara; Hidenori Koyama; Eiji Ishimura; Takami Miki; Tsutomu Tabata; Yoshiki Nishizawa
Insulin resistance as an independent predictor of cardiovascular mortality in patients with end-stage renal disease.
Journal of the American Society of Nephrology : JASN 2002;13(7):1894-900.
2002: Isao Kawasaki; Hideki Tahara; Masanori Emoto; Tetsuo Shoji; Atsushi Shioji; Yasuhisa Okuno; Masaaki Inaba; Yoshiki Nishizawa
Impact of Prol2Ala variant in the peroxisome proliferator-activated receptor (PPAR) gamma2 on obesity and insulin resistance in Japanese Type 2 diabetic and healthy subjects.
Osaka city medical journal 2002;48(1):23-8.
2002: Yasuro Kumeda; Masaaki Inaba; Hitoshi Goto; Mayumi Nagata; Yasuko Henmi; Yutaka Furumitsu; Eiji Ishimura; Kentaro Inui; Yasutaka Yutani; Takami Miki; Tetsuo Shoji; Yoshiki Nishizawa
Increased thickness of the arterial intima-media detected by ultrasonography in patients with rheumatoid arthritis.
Arthritis and rheumatism 2002;46(6):1489-97.
2002: Masaaki Inaba; Kyoko Nagasue; Senji Okuno; Misako Ueda; Yasuro Kumeda; Yasuo Imanishi; Tetsuo Shoji; Eiji Ishimura; Tomohiro Ohta; Tatsuya Nakatani; Masao Kim; Yoshiki Nishizawa
Impaired secretion of parathyroid hormone, but not refractoriness of osteoblast, is a major mechanism of low bone turnover in hemodialyzed patients with diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2002;39(6):1261-9.
2002: Tetsuo Shoji; Masanori Emoto; Tsutomu Tabata; Eiji Kimoto; Kayo Shinohara; Kiyoshi Maekawa; Takahiko Kawagishi; Hideki Tahara; Eiji Ishimura; Yoshiki Nishizawa
Advanced atherosclerosis in predialysis patients with chronic renal failure.
Kidney international 2002;61(6):2187-92.
2002: Hideki Ueda; Eiji Isimura; Senji Okuno; Kiyoshi Maekawa; Tsuyoshi Izumotani; Masao Kim; Naoki Matsumoto; Shinya Fukumoto; Yasuo Imanishi; Masanori Emoto; Tetsuo Shoji; Hideki Wanibuchi; Masaaki Inaba; Yoshiki Nishizawa
[Sibling cases of nephritis resembling membranoproliferative glomerulonephritis].
Nihon Jinzo Gakkai shi 2002;44(4):420-6.
2002: Takaaki Maeno; Hidenori Koyama; Hideki Tahara; Miyoko Komatsu; Masanori Emoto; Tetsuo Shoji; Masaaki Inaba; Takami Miki; Yasuhisa Okuno; Yoshiki Nishizawa
The 807T allele in alpha2 integrin is protective against atherosclerotic arterial wall thickening and the occurrence of plaque in patients with type 2 diabetes.
Diabetes 2002;51(5):1523-8.
2002: Naoki Matsumoto; Eiji Ishimura; Hiromichi Taniwaki; Masanori Emoto; Tetsuo Shoji; Takahiko Kawagishi; Masaaki Inaba; Yoshiki Nishizawa
Smoking and proteinuria impair vasodilatory response of intrarenal arteries to nitroglycerine in patients with type 2 diabetes mellitus.
Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association 2002;17(4):608-13.
2002: Isao Kawasaki; Hideki Tahara; Masanori Emoto; Tetsuo Shoji; Yoshiki Nishizawa
Relationship between TaqIB cholesteryl ester transfer protein gene polymorphism and macrovascular complications in Japanese patients with type 2 diabetes.
Diabetes 2002;51(3):871-4.
2002: Eiji Kimoto; Tetsuo Shoji; Masanori Emoto; Takami Miki; Tsutomu Tabata; Yasuhisa Okuno; Eiji Ishimura; Masaaki Inaba; Yoshiki Nishizawa
Effect of diabetes on uremic dyslipidemia.
Journal of atherosclerosis and thrombosis 2002;9(6):305-13.
2001: Tetsuo Shoji; Masanori Emoto; Yoshiki Nishizawa
HOMA index to assess insulin resistance in renal failure patients.
Nephron 2001;89(3):348-9.
2001: Eiji Ishimura; Tetsuo Shoji; Masanori Emoto; K Motoyama; K Shinohara; Naoki Matsumoto; Hiromichi Taniwaki; Masaaki Inaba; Yoshiki Nishizawa
Renal insufficiency accelerates atherosclerosis in patients with type 2 diabetes mellitus.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S186-90.
2001: Tetsuo Shoji; Eiji Ishimura; Masaaki Inaba; Tsutomu Tabata; Yoshiki Nishizawa
Atherogenic lipoproteins in end-stage renal disease.
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S30-3.
2001: Yoshiki Nishizawa; Tetsuo Shoji; Eiji Ishimura; Masaaki Inaba; Hirotoshi Morii
Paradox of risk factors for cardiovascular mortality in uremia: is a higher cholesterol level better for atherosclerosis in uremia?
American journal of kidney diseases : the official journal of the National Kidney Foundation 2001;38(4 Suppl 1):S4-7.
2001: Tetsuo Shoji; Masanori Emoto; Kayo Shinohara; Ryusuke Kakiya; Yoshihiro Tsujimoto; H Kishimoto; Eiji Ishimura; Tsutomu Tabata; Yoshiki Nishizawa
Diabetes mellitus, aortic stiffness, and cardiovascular mortality in end-stage renal disease.
Journal of the American Society of Nephrology : JASN 2001;12(10):2117-24.
2001: Eiji Ishimura; Senji Okuno; Masao Kim; T Yamamoto; Tsuyoshi Izumotani; T Otoshi; Tetsuo Shoji; Masaaki Inaba; Yoshiki Nishizawa
Increasing body fat mass in the first year of hemodialysis.
Journal of the American Society of Nephrology : JASN 2001;12(9):1921-6.
2001: Hiromichi Taniwaki; Tetsuo Shoji; Masanori Emoto; Takahiko Kawagishi; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Femoral artery wall thickness and stiffness in evaluation of peripheral vascular disease in type 2 diabetes mellitus.
Atherosclerosis 2001;158(1):207-14.
2001: A Yamada; Tetsuo Shoji; Hideki Tahara; Masanori Emoto; Yoshiki Nishizawa
Effect of insulin resistance on serum paraoxonase activity in a nondiabetic population.
Metabolism: clinical and experimental 2001;50(7):805-11.
2001: Tetsuo Shoji; Masanori Emoto; Takahiko Kawagishi; Eiji Kimoto; A Yamada; Tsutomu Tabata; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Atherogenic lipoprotein changes in diabetic nephropathy.
Atherosclerosis 2001;156(2):425-33.
2001: Tomoaki Morioka; Masanori Emoto; Tsutomu Tabata; Tetsuo Shoji; Hideki Tahara; H Kishimoto; Eiji Ishimura; Yoshiki Nishizawa
Glycemic control is a predictor of survival for diabetic patients on hemodialysis.
Diabetes care 2001;24(5):909-13.
2001: Tetsuo Shoji; Yoshiki Nishizawa
[Multiple risk factor syndrome].
Nihon rinsho. Japanese journal of clinical medicine 2001;59 Suppl 3():130-5.
2001: Masanori Emoto; H Kanda; Tetsuo Shoji; Takahiko Kawagishi; Miyoko Komatsu; Katsuhito Mori; Hideki Tahara; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Yoshiki Nishizawa
Impact of insulin resistance and nephropathy on homocysteine in type 2 diabetes.
Diabetes care 2001;24(3):533-8.
2000: Tetsuo Shoji; Takahiko Kawagishi; Masanori Emoto; K Maekawa; Hiromichi Taniwaki; H Kanda; Y Nishizawa
Additive impacts of diabetes and renal failure on carotid atherosclerosis.
Atherosclerosis 2000;153(1):257-8.
2000: Tetsuo Shoji; Eiji Kimoto; A Yamada; Masanori Emoto; Takahiko Kawagishi; T Tabata; Y Nishizawa
Elevated plasma free apo(a) levels in hemodialysis patients.
Nephron 2000;86(3):389-90.
2000: Naoki Matsumoto; Eiji Ishimura; Hiromichi Taniwaki; Masanori Emoto; Tetsuo Shoji; Takahiko Kawagishi; Masaaki Inaba; Yoshiki Nishizawa
Diabetes mellitus worsens intrarenal hemodynamic abnormalities in nondialyzed patients with chronic renal failure.
Nephron 2000;86(1):44-51.
2000: Hiromichi Taniwaki; Eiji Ishimura; Masanori Emoto; Takahiko Kawagishi; Naoki Matsumoto; Tetsuo Shoji; T Okamura; Masaaki Inaba; Yoshiki Nishizawa
Relationship between urinary albumin excretion and glomerular filtration rate in normotensive, nonproteinuric patients with type 2 diabetes mellitus.
Nephron 2000;86(1):36-43.
2000: M Fukumoto; Tetsuo Shoji; Masanori Emoto; Takahiko Kawagishi; Yasuhisa Okuno; Yoshiki Nishizawa
Antibodies against oxidized LDL and carotid artery intima-media thickness in a healthy population.
Arteriosclerosis, thrombosis, and vascular biology 2000;20(3):703-7.
2000: Tetsuo Shoji; Yoshiki Nishizawa; M Fukumoto; K Shimamura; J Kimura; H Kanda; Masanori Emoto; Takahiko Kawagishi; Hirotoshi Morii
Inverse relationship between circulating oxidized low density lipoprotein (oxLDL) and anti-oxLDL antibody levels in healthy subjects.
Atherosclerosis 2000;148(1):171-7.
1999: Yoshihiro Tsujimoto; Tetsuo Shoji; Tsutomu Tabata; A Morita; Masanori Emoto; Yoshiki Nishizawa; Hirotoshi Morii
Leptin in peritoneal dialysate from continuous ambulatory peritoneal dialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1999;34(5):832-8.
1999: Hiromichi Taniwaki; Takahiko Kawagishi; Masanori Emoto; Tetsuo Shoji; Masayuki Hosoi; K Kogawa; Yoshiki Nishizawa; Hirotoshi Morii
Association of ACE gene polymorphism with arterial stiffness in patients with type 2 diabetes.
Diabetes care 1999;22(11):1858-64.
1999: Hiromichi Taniwaki; Takahiko Kawagishi; Masanori Emoto; Tetsuo Shoji; H Kanda; Kiyoshi Maekawa; Yoshiki Nishizawa; Hirotoshi Morii
Correlation between the intima-media thickness of the carotid artery and aortic pulse-wave velocity in patients with type 2 diabetes. Vessel wall properties in type 2 diabetes.
Diabetes care 1999;22(11):1851-7.
1999: Yoshiki Nishizawa; Tetsuo Shoji; Tsutomu Tabata; Takashi Inoue; Hirotoshi Morii
Effects of lipid-lowering drugs on intermediate-density lipoprotein in uremic patients.
Kidney international. Supplement 1999;71():S134-6.
1999: Masanori Emoto; Yoshiki Nishizawa; Kiyoshi Maekawa; Yoshikazu Hiura; H Kanda; Takahiko Kawagishi; Tetsuo Shoji; Yasuhisa Okuno; Hirotoshi Morii
Homeostasis model assessment as a clinical index of insulin resistance in type 2 diabetic patients treated with sulfonylureas.
Diabetes care 1999;22(5):818-22.
1998: Masanori Emoto; Yoshiki Nishizawa; Takahiko Kawagishi; Kiyoshi Maekawa; Yoshikazu Hiura; H Kanda; K Izumotani; Tetsuo Shoji; Eiji Ishimura; Masaaki Inaba; Yasuhisa Okuno; Hirotoshi Morii
Stiffness indexes beta of the common carotid and femoral arteries are associated with insulin resistance in NIDDM.
Diabetes care 1998;21(7):1178-82.
1998: Tetsuo Shoji; Yoshiki Nishizawa; Takahiko Kawagishi; K Kawasaki; Hiromichi Taniwaki; Tsutomu Tabata; T Inoue; Hirotoshi Morii
Intermediate-density lipoprotein as an independent risk factor for aortic atherosclerosis in hemodialysis patients.
Journal of the American Society of Nephrology : JASN 1998;9(7):1277-84.
1998: Yoshiki Nishizawa; Tetsuo Shoji; S Tanaka; M Yamashita; A Morita; Masanori Emoto; Tsutomu Tabata; Takashi Inoue; Hirotoshi Morii
Plasma leptin level and its relationship with body composition in hemodialysis patients.
American journal of kidney diseases : the official journal of the National Kidney Foundation 1998;31(4):655-61.
1997: Yoshiki Nishizawa; Tetsuo Shoji; Takahiko Kawagishi; Hirotoshi Morii
Atherosclerosis in uremia: possible roles of hyperparathyroidism and intermediate density lipoprotein accumulation.
Kidney international. Supplement 1997;62():S90-2.
1997: Tetsuo Shoji; Yoshiki Nishizawa; Masanori Emoto; Kiyoshi Maekawa; Yoshikazu Hiura; S Tanaka; Takahiko Kawagishi; Yasuhisa Okuno; Hirotoshi Morii
Renal function and insulin resistance as determinants of plasma leptin levels in patients with NIDDM.
Diabetologia 1997;40(6):676-9.
1997: Tetsuo Shoji; Yoshiki Nishizawa; Takahiko Kawagishi; M Tanaka; K Kawasaki; Tsutomu Tabata; Takashi Inoue; Hirotoshi Morii
Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis.
Atherosclerosis 1997;131(2):229-36.
1997: K Kogawa; Yoshiki Nishizawa; Masayuki Hosoi; Takahiko Kawagishi; Kiyoshi Maekawa; Tetsuo Shoji; Yasuhisa Okuno; Hirotoshi Morii
Effect of polymorphism of apolipoprotein E and angiotensin-converting enzyme genes on arterial wall thickness.
Diabetes 1997;46(4):682-7.
1996: Masayuki Hosoi; Yoshiki Nishizawa; K Kogawa; Takahiko Kawagishi; T Konishi; Kiyoshi Maekawa; Masanori Emoto; Shinya Fukumoto; Atsushi Shioi; Tetsuo Shoji; Masaaki Inaba; Yasuhisa Okuno; Hirotoshi Morii
Angiotensin-converting enzyme gene polymorphism is associated with carotid arterial wall thickness in non-insulin-dependent diabetic patients.
Circulation 1996;94(4):704-7.
1995: Takahiko Kawagishi; Yoshiki Nishizawa; T Konishi; K Kawasaki; Masanori Emoto; Tetsuo Shoji; Tsutomu Tabata; T Inoue; Hirotoshi Morii
High-resolution B-mode ultrasonography in evaluation of atherosclerosis in uremia.
Kidney international 1995;48(3):820-6.
1995: Yoshiki Nishizawa; Tetsuo Shoji; Masanori Emoto; K Kawasaki; T Konishi; Tsutomu Tabata; T Inoue; Hirotoshi Morii
Reduction of intermediate density lipoprotein by pravastatin in hemo- and peritoneal dialysis patients.
Clinical nephrology 1995;43(4):268-77.
1993: Yoshiki Nishizawa; Tetsuo Shoji; H Nishitani; M Yamakawa; T Konishi; K Kawasaki; Hirotoshi Morii
Hypertriglyceridemia and lowered apolipoprotein C-II/C-III ratio in uremia: effect of a fibric acid, clinofibrate.
Kidney international 1993;44(6):1352-9.
1992: Tetsuo Shoji; Yoshiki Nishizawa; H Nishitani; M Yamakawa; Hirotoshi Morii
High serum lipoprotein(a) concentrations in uremic patients treated with continuous ambulatory peritoneal dialysis.
Clinical nephrology 1992;38(5):271-6.
1992: Tetsuo Shoji; Yoshiki Nishizawa; H Koyama; S Hagiwara; H Aratani; K Sasao; H Kishimoto; H Tanishita; Hirotoshi Morii
High-density-lipoprotein metabolism during a very-low-calorie diet.
The American journal of clinical nutrition 1992;56(1 Suppl):297S-298S.
1992: Yoshiki Nishizawa; H Koyama; Tetsuo Shoji; H Tahara; S Hagiwara; H Aratani; Kiyoshi Nakatsuka; Takami Miki; Hirotoshi Morii
Altered calcium homeostasis accompanying changes of regional bone mineral during a very-low-calorie diet.
The American journal of clinical nutrition 1992;56(1 Suppl):265S-267S.
1992: Tetsuo Shoji; Yoshiki Nishizawa; H Nishitani; M Yamakawa; Hirotoshi Morii
Impaired metabolism of high density lipoprotein in uremic patients.
Kidney international 1992;41(6):1653-61.
1991: Yoshiki Nishizawa; H Koyama; Tetsuo Shoji; H Aratani; S Hagiwara; Takami Miki; Hirotoshi Morii
Obesity as a determinant of regional bone mineral density.
Journal of nutritional science and vitaminology 1991;37 Suppl():S65-70.
1991: Tetsuo Shoji; Yoshiki Nishizawa; H Koyama; S Hagiwara; H Aratani; K Izumotani-Sasao; H Kishimoto; H Tanishita; Hirotoshi Morii
Lipoprotein metabolism in normolipidemic obese women during very low calorie diet: changes in high density lipoprotein.
Journal of nutritional science and vitaminology 1991;37 Suppl():S57-64.
1991: Tetsuo Shoji; Yoshiki Nishizawa; H Nishitani; M Yamakawa; Hirotoshi Morii
Roles of hypoalbuminemia and lipoprotein lipase on hyperlipoproteinemia in continuous ambulatory peritoneal dialysis.
Metabolism: clinical and experimental 1991;40(10):1002-8.
1991: H Koyama; H Tahara; Tetsuo Shoji; Yoshiki Nishizawa; Masaaki Inaba; Shuzo Otani; M Yanagisawa; Y Ishiguro; N Takanashi; Hirotoshi Morii
Uremic serum contains humoral factor(s) larger than fifty kilodaltons which suppresses endothelin production in cultured endothelial cells.
Contributions to nephrology 1991;90():111-5.